Quetiapine Fumarate 50 mg/1 (Quetiapine Fumarate TABLET, FILM COATED) 50 mg/1

Quetiapine Fumarate 50 mg tablets are used to manage certain mental health conditions. This medication is designed to help balance chemicals in the brain for improved well-being.

Strength

50 mg/1

Pack Size

100 TABLET, FILM COATED in 1 BOTTLE (16571-718-01)

Manufacturer / TM Owner

Rising Pharma Holdings, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Quetiapine Fumarate is commonly used to treat symptoms associated with schizophrenia and bipolar disorder. It may also be prescribed for other mental health conditions as determined by a healthcare provider. The primary use of Quetiapine Fumarate is to help manage and alleviate symptoms related to these conditions.

Side Effects

Quetiapine Fumarate may cause drowsiness, dizziness, and dry mouth. Some users report weight gain and low blood pressure. Effects can vary, and it's important to monitor how the body responds to this medication.

Precautions & Warnings

Quetiapine Fumarate should be handled with care. It is important to follow the guidance of a healthcare provider regarding its use. Avoid activities that require alertness until the effects of the medication are known. Store in a cool, dry place away from children.

Avoid Interactions

Quetiapine Fumarate may interact with alcohol and other medications that cause drowsiness. It is important to inform a healthcare provider about all medications being taken to avoid potential interactions. Always consult a healthcare provider before starting or stopping any medication.

Frequently Asked Questions

Quetiapine Fumarate is primarily used to manage symptoms of schizophrenia and bipolar disorder. It may also be prescribed for other mental health conditions.

Quetiapine Fumarate is typically taken orally as directed by a healthcare provider. It is important to follow the prescribed dosage and schedule.

Common side effects include drowsiness, dizziness, dry mouth, weight gain, and low blood pressure. Individual responses may vary.

Quetiapine Fumarate may interact with other medications, especially those that cause drowsiness. Always consult a healthcare provider before combining medications.

Long-term use of Quetiapine Fumarate should be monitored by a healthcare provider. Regular check-ups are important to assess its continued suitability.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.